Identification of a new NEMO/TRAF6 interface affected in incontinentia pigmenti pathology

Human Molecular Genetics

Volumn 19, Issue 16, 2010, Pages 3138-3149

  Gautheron, Jérémie ^a   Pescatore, Alessandra ^b   Fusco, Francesca ^b   Esposito, Elio ^b   Yamaoka, Shoji ^c   Agou, Fabrice ^d   Ursini, Matilde Valeria ^b   Courtois, Gilles ^a  

^a INSERM   (France)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; GENE MUTATION; HUMAN; HUMAN CELL; INCONTINENTIA PIGMENTI; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 77955015392     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq222     Document Type: Article

References (45)

1. Karin, M. and Ben-Neriah, Y. (2000) Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu. Rev. Immunol., 18, 621-663.
2. Hayden, M.S. and Ghosh, S. (2008) Shared principles in NF-kB signaling. Cell, 132, 344-362.
3. Scheidereit, C. (2006) IkB kinase complexes: gateways to NF-kB activation and transcription. Oncogene, 25, 6685-6705.
4. Hayden, M.S. and Ghosh, S. (2004) Signaling to NF-kB. Genes Dev., 18, 2195-2224.
5. Landy, S.J. and Donnai, D. (1993) Incontinentia pigmenti (Bloch-Sulzberger syndrome). J. Med. Genet., 30, 53-59.
6. Smahi, A., Courtois, G., Vabres, P., Yamaoka, S., Heuertz, S., Munnich, A., Israël, A., Heiss, N.S., Klauck, S.M., Kioschis, P. et al. (2000) Genomic rearrangement in NEMO impairs NF-kB activation and is a cause of incontinentia pigmenti. Nature, 405, 466-472.
7. Courtois, G. and Smahi, A. (2006) NF-kB-related genetic diseases. Cell Death Differ., 13, 843-851.
8. Nelson, D.L. (2006) NEMO, NF-kB signaling and incontinentia pigmenti. Curr. Opin. Genet. Dev., 16, 282-288.
9. Fusco, F., Pescatore, A., Bal, E., Ghoul, A., Paciolla, M., Lioi, M.B., D'Urso, M., Rabia, S.H., Bodemer, C., Bonnefont, J.P. et al. (2008) Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations. Hum. Mutat., 29, 595-604.
10. Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C. and Chen, Z.J. (2000) Activation of the IkB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell, 103, 351-361.
11. Pickart, C.M. and Eddins, M.J. (2004) Ubiquitin: structures, functions, mechanisms. Biochim. Biophys. Acta, 1695, 55-72.
12. Deshaies, R.J. and Joazeiro, C.A. (2009) RING domain E3 ubiquitin ligases. Annu. Rev. Biochem., 78, 399-434.
13. Hurley, J.H., Lee, S. and Prag, G. (2006) Ubiquitin-binding domains. Biochem. J., 399, 361-372.
14. Skaug, B., Jiang, X. and Chen, Z.J. (2009) The role of ubiquitin in NF-kB regulatory pathways. Annu. Rev. Biochem., 78, 769-796.
15. Sun, S.C. (2008) Deubiquitylation and regulation of the immune response. Nat. Rev. Immunol., 8, 501-511.
16. Wertz, I.E. and Dixit, V.M. (2010) Regulation of death receptor signaling by the ubiquitin system. Cell Death Differ., 17, 14-24.
17. Yamazaki, K., Gohda, J., Kanayama, A., Miyamoto, Y., Sakurai, H., Yamamoto, M., Akira, S., Hayashi, H., Su, B. and Inoue, J. (2009) Two mechanistically and temporally distinct NF-kB activation pathways in IL-1 signaling. Sci. Signal., 2, ra66.
18. Sebban, H., Yamaoka, S. and Courtois, G. (2006) Posttranslational modifications of NEMO and its partners in NF-kB signaling. Trends Cell. Biol., 16, 569-577.
19. Sebban-Benin, H., Pescatore, A., Fusco, F., Pascuale, V., Gautheron, J., Yamaoka, S., Moncla, A., Ursini, M.V. and Courtois, G. (2007) Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. Hum. Mol. Genet., 16, 2805-2815.
20. Marienfeld, R.B., Palkowitsch, L. and Ghosh, S. (2006) Dimerization of the IkB kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-kB activity. Mol. Cell. Biol., 26, 9209-9219.
21. Fusco, F., Bardaro, T., Fimiani, G., Mercadante, V., Miano, M.G., Falco, G., Israël, A., Courtois, G., D'Urso, M. and Ursini, M.V. (2004) Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kB activation. Hum. Mol. Genet., 13, 1763-1773.
22. Rushe, M., Silvian, L., Bixler, S., Chen, L.L., Cheung, A., Bowes, S., Cuervo, H., Berkowitz, S., Zheng, T., Guckian, K. et al. (2008) Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site. Structure, 16, 798-808.
23. Courtois, G., Whiteside, S.T., Sibley, C.H. and Israël, A. (1997) Characterization of a mutant cell line that does not activate NF-kBin response to multiple stimuli. Mol. Cell Biol., 17, 1441-1449.
24. Schmidt-Supprian, M., Bloch, W., Courtois, G., Addicks, K., Israël, A., Rajewsky, K. and Pasparakis, M. (2000) NEMO/IKKγ-deficient mice model incontinentia pigmenti. Mol. Cell, 5, 981-992.
25. Lo, Y.C., Lin, S.Y., Rospigliosi, C.C., Conze, D.B., Wu, C.J., Ashwell, J.D., Eliezer, D. and Wu, H. (2009) Structural basis for recognition of diubiquitins by NEMO. Mol. Cell., 33, 602-615.
26. Grubisha, O., Kaminska, M., Duquerroy, S., Fontan, E., Cordier, F., Haouz, A., Raynal, B., Chiaravalli, J., Delepierre, M., Israël, A. et al. (2010) DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding. J. Mol. Biol., 395, 89-104.
27. Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D. and Courtois, G. (2003) The tumour suppressor CYLD negatively regulates NF-kB signalling by deubiquitination. Nature, 424, 801-805.
28. Kanayama, A., Seth, R.B., Sun, L., Ea, C.K., Hong, M., Shaito, A., Chiu, Y.H., Deng, L. and Chen, Z.J. (2004) TAB2 and TAB3 activate the NF-kB pathway through binding to polyubiquitin chains. Mol. Cell., 15, 535-548.
29. Walsh, M.C., Kim, G.K., Maurizio, P.L., Molnar, E.E. and Choi, Y. (2008) TRAF6 autoubiquitination-independent activation of the NF-kB and MAPK pathways in response to IL-1 and RANKL. PLoS ONE, 3, e4064.
30. Lamothe, B., Campos, A.D., Webster, W.K., Gopinathan, A., Hur, L. and Darnay, B.G. (2008) The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL. J. Biol. Chem., 283, 24871-24880.
31. Conze, D.B., Wu, C.J., Thomas, J.A., Landstrom, A. and Ashwell, J.D. (2008) Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor and toll-like receptor-mediated NF-kB activation. Mol. Cell Biol., 28, 3538-3547.
32. Windheim, M., Stafford, M., Peggie, M. and Cohen, P. (2008) Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IκBα kinase. Mol. Cell. Biol., 28, 1783-1791.
33. Sun, L., Deng, L., Ea, C.K., Xia, Z.P. and Chen, Z.J. (2004) The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell., 14, 289-301.
34. tokunaga, F., Sakata, S., Saeki, Y., Satomi, Y., Kirisako, T., Kamei, K., Nakagawa, T., Kato, M., Murata, S., Yamaoka, S. et al. (2009) Involvement of linear polyubiquitylation of NEMO in NF-kB activation. Nat. Cell. Biol., 11, 123-132.
35. Leonardi, A., Chariot, A., Claudio, E., Cunningham, K. and Siebenlist, U. (2000) CIKS, a connection to IkB kinase and stress-activated protein kinase. Proc. Natl Acad. Sci. USA, 97, 10494-10499.
36. Wu, Z.H., Shi, Y., Tibbetts, R.S. and Miyamoto, S. (2006) Molecular linkage between the kinase ATM and NF-kB signaling in response to genotoxic stimuli. Science, 311, 1141-1146.
37. Mabb, A.M., Wuerzberger-Davis, S.M. and Miyamoto, S. (2006) PIASy mediates NEMO sumoylation and NF-kB activation in response to genotoxic stress. Nat. Cell. Biol., 8, 986-993.
38. Napolitano, G., Mirra, S., Monfregola, J., Lavorgna, A., Leonardi, A. and Ursini, M.V. (2009) NESCA: a new NEMO/IKKgamma and TRAF6 interacting protein. J. Cell. Physiol., 220, 410-417.
39. Yang, K., Zhu, J., Sun, S., Tang, Y., Zhang, B., Diao, L. and Wang, C. (2004) The coiled-coil domain of TRAF6 is essential for its auto-ubiquitination. Biochem. Biophys. Res. Commun., 324, 432-439.
40. Yin, Q., Lin, S.C., Lamothe, B., Lu, M., Lo, Y.C., Hura, G., Zheng, L., Rich, R.L., Campos, A.D., Myszka, D.G. et al. (2009) E2 interaction and dimerization in the crystal structure of TRAF6. Nat. Struct. Mol. Biol., 16, 658-666.
41. Nenci, A., Huth, M., Funteh, A., Schmidt-Supprian, M., Bloch, W., Metzger, D., Chambon, P., Rajewsky, K., Krieg, T., Haase, I. et al. (2006) Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. Hum. Mol. Genet., 15, 531-542.
42. Döffinger, R., Smahi, A., Bessia, C., Geissmann, F., Feinberg, J., Durandy, A., Bodemer, C., Kenwrick, S., Dupuis-Girod, S., Blanche, S. et al. (2001) X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kB signaling. Nat. Genet., 27, 277-285.
43. Naito, A., Yoshida, H., Nishioka, E., Satoh, M., Azuma, S., Yamamoto, T., Nishikawa, S. and Inoue, J. (2002) TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc. Natl Acad. Sci. USA, 99, 8766-8771.
44. Gentry, J.J., Rutkoski, N.J., Burke, T.L. and Carter, B.D. (2004) A functional interaction between the p75 neurotrophin receptor interacting factors, TRAF6 and NRIF. J. Biol. Chem., 279, 16646-16656.
45. Conze, D.B., Wu, C.J., Thomas, J.A., Landstrom, A. and Ashwell, J.D. (2008) Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor and toll-like receptor-mediated NF-kB activation. Mol Cell Biol., 28, 3538-3547.